ICCM:NASDAQ, IceCure Medical Ltd

ICCM stock overview

IceCure Medical Ltd (ICCM:NASDAQ) closed at $0.760 on November 16, 2026, up 4.12% on the day. The stock trades 96.6% below its 52-week high of $22.50 and 16.9% above its 52-week low of $0.650. Over the past year, it lost 96.5%. IceCure Medical Ltd is part of the Health Care sector.

Key figures

Price
$0.760
Day change
+4.12%
Volume
202,290
Average volume
155,732
Market cap
3M+
52-week range
$0.650 – $22.50
50-day average
$1.35
200-day average
$6.99

Price action over the past year

In 252 trading sessions since November 14, 2025, ICCM closed higher on 97 days (38%). Its best day was June 17, 2026 (+200.47%) and its worst was March 26, 2026 (-33.67%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

ICCM news

About IceCure Medical Ltd

Icecure Medical Ltd is a Israel based firm which develops and markets minimally invasive cryoablation therapies for women's health. The company provides a minimally invasive, in-office definitive treatment for symptomatic breast fibroadenoma.

Similar stocks

Find more stocks like ICCM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.